SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055240
Filing Date
2021-11-08
Accepted
2021-11-08 16:06:01
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q stok-10q_20210930.htm   iXBRL 10-Q 2448539
2 EX-10.1 stok-ex101_235.htm EX-10.1 347375
3 EX-10.2 stok-ex102_236.htm EX-10.2 20178
4 EX-31.1 stok-ex311_6.htm EX-31.1 18397
5 EX-31.2 stok-ex312_7.htm EX-31.2 18294
6 EX-32.1 stok-ex321_10.htm EX-32.1 7204
7 EX-32.2 stok-ex322_8.htm EX-32.2 7877
8 GRAPHIC gw21bqpfrkyv000001.jpg GRAPHIC 74055
  Complete submission text file 0001564590-21-055240.txt   7346722

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA stok-20210930.xsd EX-101.SCH 43004
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stok-20210930_cal.xml EX-101.CAL 42085
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stok-20210930_def.xml EX-101.DEF 91210
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE stok-20210930_lab.xml EX-101.LAB 297254
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stok-20210930_pre.xml EX-101.PRE 214487
14 EXTRACTED XBRL INSTANCE DOCUMENT stok-10q_20210930_htm.xml XML 1090247
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38938 | Film No.: 211387922
SIC: 2834 Pharmaceutical Preparations